Literature DB >> 14556933

Acquisition of anoikis resistance in human osteosarcoma cells.

C M Díaz-Montero1, B W McIntyre.   

Abstract

Under normal circumstances, adhered cells die of anoikis when detached from their extracellular matrix (ECM). Resistance to anoikis has been implicated in the progression of many human malignancies by affording an increased survival time in the absence of matrix attachment, facilitating the migration and eventual colonisation of distant sites. In this study, an anoikis-resistant variant of the human osteosarcoma cell line, SAOS-2 (SAOSar), was generated by sequential cycles of culturing under adhered and suspended conditions. It was also shown that although parental SAOS (SAOSp) cells are a heterogeneous population with varying levels of sensitivity to anoikis, the establishment of anoikis-resistant clones was not necessarily the result of mere selection of a previously resistant subpopulation. Anoikis-resistant cells were also derived from anoikis-sensitive SAOS clones by exposure to anoikis-inducing culture conditions. This suggests that lack of the normal signalling generated by attachment to the ECM could represent a driving force towards anoikis resistance. Resistance to anoikis could not be attributed to a general defect in the apoptotic pathway since apoptosis in both sensitive and resistant populations was induced after treatment with staurosporine, cycloheximide and hydrogen peroxide. This suggests that the apoptotic machinery is intact in both anoikis-sensitive and -resistant SAOS cells and that the death signal in anoikis-sensitive cells is generated by the lack of attachment, most probably by unligated integrins. Anoikis-resistant cells have circumvented this death signal and remain viable despite suspended conditions.

Entities:  

Keywords:  Non-programmatic

Mesh:

Substances:

Year:  2003        PMID: 14556933     DOI: 10.1016/s0959-8049(03)00575-6

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  9 in total

1.  RhoGDIbeta lacking the N-terminal regulatory domain suppresses metastasis by promoting anoikis in v-src-transformed cells.

Authors:  Takahide Ota; Masayo Maeda; Shiho Sakita-Suto; Xinwen Zhou; Manabu Murakami; Tsutomu Takegami; Masaaki Tatsuka
Journal:  Clin Exp Metastasis       Date:  2006-11-17       Impact factor: 5.150

2.  Slow down to stay alive: HER4 protects against cellular stress and confers chemoresistance in neuroblastoma.

Authors:  Yingqi Hua; Kirill Gorshkov; Yanwen Yang; Wenyi Wang; Nianxiang Zhang; Dennis P M Hughes
Journal:  Cancer       Date:  2012-03-13       Impact factor: 6.860

3.  Caveolin-1 regulates metastatic behaviors of anoikis resistant lung cancer cells.

Authors:  Pithi Chanvorachote; Varisa Pongrakhananon; Hasseri Halim
Journal:  Mol Cell Biochem       Date:  2014-10-29       Impact factor: 3.396

4.  Melanocyte transformation associated with substrate adhesion impediment.

Authors:  Sueli M Oba-Shinjo; Mariangela Correa; Tatiana I Ricca; Fernanda Molognoni; Maria A Pinhal; Izabel A Neves; Sueli K Marie; Lúcia O Sampaio; Helena B Nader; Roger Chammas; Miriam G Jasiulionis
Journal:  Neoplasia       Date:  2006-03       Impact factor: 5.715

5.  Tissue inhibitor of metalloproteinase 1 expression associated with gene demethylation confers anoikis resistance in early phases of melanocyte malignant transformation.

Authors:  Tatiana I Ricca; Gangning Liang; Ana Paula M Suenaga; Sang W Han; Peter A Jones; Miriam G Jasiulionis
Journal:  Transl Oncol       Date:  2009-12       Impact factor: 4.243

6.  Molecular alterations associated with osteosarcoma development.

Authors:  Kosei Ando; Kanji Mori; Franck Verrecchia; Baud'huin Marc; Françoise Rédini; Dominique Heymann
Journal:  Sarcoma       Date:  2012-02-15

7.  Acquisition of anoikis resistance in human osteosarcoma cells does not alter sensitivity to chemotherapeutic agents.

Authors:  C Marcela Díaz-Montero; Bradley W McIntyre
Journal:  BMC Cancer       Date:  2005-04-13       Impact factor: 4.430

8.  Anoikis-resistant subpopulations of human osteosarcoma display significant chemoresistance and are sensitive to targeted epigenetic therapies predicted by expression profiling.

Authors:  Jessica M Foley; Donald J Scholten; Noel R Monks; David Cherba; David J Monsma; Paula Davidson; Dawna Dylewski; Karl Dykema; Mary E Winn; Matthew R Steensma
Journal:  J Transl Med       Date:  2015-04-02       Impact factor: 5.531

Review 9.  The importance of being dead: cell death mechanisms assessment in anti-sarcoma therapy.

Authors:  Santiago Rello-Varona; David Herrero-Martín; Laura Lagares-Tena; Roser López-Alemany; Núria Mulet-Margalef; Juan Huertas-Martínez; Silvia Garcia-Monclús; Xavier García Del Muro; Cristina Muñoz-Pinedo; Oscar Martínez Tirado
Journal:  Front Oncol       Date:  2015-04-07       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.